-The Indian Express The latest NSSO data also underlines the increasing absence of women from the labour market Every time results from one of the "thick" rounds of the National Sample Survey come out, we get into a feeding frenzy, trying to slice and dice the statistics for changes since the previous round. Since NSS large rounds are typically conducted every five years, there is perhaps some sense to it, particularly when...

-Outlook As the Manmohan Singh government makes evident its unfriendliness to villages, the nation hurtles towards disaster. It's a danger no one wants to face. Prime Minister Manmohan Singh has been trying for years to make us believe that agriculture is a vast marshland in which a huge population is stuck ankle- to neck-deep and it is his duty to rescue them. "Our salvation lies in moving people out of agriculture," he...

-The Business Standard NAC shouldn't have seen growth as the enemy of welfare For the nine years of the United Progressive Alliance government, the National Advisory Council led by Sonia Gandhi and including many well-known people from the corporate and non-governmental organisation world - mostly those with a left-of-centre perspective - has been the focus of much attention. The conventional narrative is that the NAC represented Sonia Gandhi's socialist instincts, and regularly...

-Economic and Political Weekly   A report on the 2013 deliberation of the Kolkata Group at its 10th workshop which focused on healthcare, the status of women and social justice in India. A K Shiva Kumar (akshivakumar@gmail.com) is convener of the Kolkata Group workshops which are organised by Pratichi (India) Trust, the Harvard Global Equity Initiative and UNICEF India. At the 10th annual Kolkata Group workshop in February this year, 40 policymakers, development practitioners,...

-The Economic Times Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts: * You think you...